BRAF and thyroid cancer: Using this logic, the team of Chakravarty et al. (2) demonstrated proof of principle that inhibition of the MAPK pathway in the transgenic model of mutant BRAF-induced thyroid cancer partially restored radioactive iodine (RAI) uptake mechanisms within the cancer cell, sufficient to both increase RAI uptake and prolong retention in the cell.